Mersana Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Mersana Therapeutics, Inc.‘s stocks are currently a part of 152 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 101.64M shares of Mersana Therapeutics, Inc.. Compared to the previous quarter, the number grew by 10.23% or 9.42M shares more. As for the holding position changes, 45.39% (69) of current hedge fund investors increased the number of shares held, 24.34% (37) of current holders sold a part of the shares held, and 11.84% (18) closed the holdings completely. 21 hedge funds are new holders of Mersana Therapeutics, Inc. stock in Q4 2022, it is 13.82% of total holders.
Hedge funds holding Mersana Therapeutics (Q1 2018 – Q4 2022)
| Q1 2018 | 56 |
|---|---|
| Q2 2018 | 53 |
| Q3 2018 | 46 |
| Q4 2018 | 48 |
| Q1 2019 | 65 |
| Q2 2019 | 77 |
| Q3 2019 | 76 |
| Q4 2019 | 70 |
| Q1 2020 | 82 |
| Q2 2020 | 130 |
| Q3 2020 | 134 |
| Q4 2020 | 151 |
| Q1 2021 | 132 |
| Q2 2021 | 131 |
| Q3 2021 | 109 |
| Q4 2021 | 123 |
| Q1 2022 | 128 |
| Q2 2022 | 122 |
| Q3 2022 | 149 |
| Q4 2022 | 152 |
Hedge funds changes in Mersana Therapeutics positions (Q1 2018 – Q4 2022)
| Q1 2018 | 13 | 29 | 9 | 6 | -1 |
|---|---|---|---|---|---|
| Q2 2018 | 11 | 20 | 12 | 14 | -4 |
| Q3 2018 | 3 | 21 | 8 | 10 | 4 |
| Q4 2018 | 9 | 12 | 15 | 6 | 6 |
| Q1 2019 | 21 | 26 | 9 | 4 | 5 |
| Q2 2019 | 20 | 33 | 13 | 6 | 5 |
| Q3 2019 | 6 | 33 | 22 | 7 | 8 |
| Q4 2019 | 13 | 24 | 22 | 19 | -8 |
| Q1 2020 | 25 | 34 | 13 | 10 | 0 |
| Q2 2020 | 54 | 51 | 22 | 6 | -3 |
| Q3 2020 | 25 | 55 | 38 | 20 | -4 |
| Q4 2020 | 34 | 54 | 45 | 17 | 1 |
| Q1 2021 | 18 | 55 | 46 | 36 | -23 |
| Q2 2021 | 18 | 51 | 40 | 20 | 2 |
| Q3 2021 | 11 | 45 | 34 | 32 | -13 |
| Q4 2021 | 31 | 45 | 25 | 16 | 6 |
| Q1 2022 | 22 | 48 | 38 | 17 | 3 |
| Q2 2022 | 15 | 51 | 35 | 19 | 2 |
| Q3 2022 | 40 | 61 | 27 | 13 | 8 |
| Q4 2022 | 21 | 69 | 37 | 18 | 7 |
Hedge funds changes in Mersana Therapeutics stock options (Q1 2018 – Q4 2022)
| Q1 2018 | 0 | 0 |
|---|---|---|
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 58,000 |
| Q2 2020 | 8,498,000 | 1,349,000 |
| Q3 2020 | 9,828,000 | 2,971,000 |
| Q4 2020 | 12,051,000 | 5,271,000 |
| Q1 2021 | 10,762,000 | 9,729,000 |
| Q2 2021 | 37,000 | 3,749,000 |
| Q3 2021 | 1,218,000 | 1,568,000 |
| Q4 2021 | 92,000 | 1,030,000 |
| Q1 2022 | 42,000 | 372,000 |
| Q2 2022 | 19,000 | 202,000 |
| Q3 2022 | 107,000 | 9,000 |
| Q4 2022 | 511,820 | 468,800 |